Log in to save to my catalogue

Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease res...

Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease res...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b98b0de562c46278bfaa2338d3ecaf8

Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease research

About this item

Full title

Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease research

Publisher

London: Nature Publishing Group UK

Journal title

NPJ digital medicine, 2024-09, Vol.7 (1), p.232-6, Article 232

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The Remote Assessment of Disease and Relapse – Alzheimer’s Disease (RADAR-AD) consortium evaluated remote measurement technologies (RMTs) for assessing functional status in AD. The consortium engaged with the European Medicines Agency (EMA) to obtain feedback on identification of meaningful functional domains, selection of RMTs and clinical study d...

Alternative Titles

Full title

Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease research

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2b98b0de562c46278bfaa2338d3ecaf8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b98b0de562c46278bfaa2338d3ecaf8

Other Identifiers

ISSN

2398-6352

E-ISSN

2398-6352

DOI

10.1038/s41746-024-01211-8

How to access this item